Short answer: Per the FDA label, the Wegovy pill starts at 1.5 mg once daily for days 1–30, then 4 mg for days 31–60 and 9 mg for days 61–90, reaching 25 mg once-daily maintenance on day 91 (2.3, Table 2). The label's schedule calls for one tablet each morning on an empty stomach with up to 4 ounces of water.
Per label section 1, Wegovy tablets are used with a reduced-calorie diet and increased physical activity to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight, and to reduce excess body weight and maintain weight reduction long term in adults with obesity, or with overweight plus at least one weight-related condition. This page summarizes the current FDA prescribing information (revised 6/2026). It is not personalized medical advice; your prescriber sets your dose.
The label's dosing schedule (label section 2.3, Table 2):
| Period | Dose | Label note |
|---|---|---|
| Days 1–30 | 1.5 mg once daily | Starting dosage |
| Days 31–60 | 4 mg once daily | Dosage escalation |
| Days 61–90 | 9 mg once daily | Dosage escalation |
| Day 91 onward | 25 mg once daily | Maintenance dosage |
Maintenance: The label's recommended maintenance dosage is 25 mg once daily for cardiovascular risk reduction and weight reduction in adults, which is also the highest tablet strength (2.3, 3). The label limits use to one tablet per day (2.1).
Below is the label schedule laid out period by period, using the earliest timing the label allows. The label lets prescribers stay at a step longer, so a real calendar is often slower. The blank columns are for your own record.
| Period | Label dose | Date | Site / time | Weight | Notes |
|---|---|---|---|---|---|
| Days 1–30 | 1.5 mg once daily | ||||
| Days 31–60 | 4 mg once daily | ||||
| Days 61–90 | 9 mg once daily | ||||
| Day 91 onward | 25 mg once daily |
Printing this page prints the schedule and calendar without the site navigation.
| Product | What it delivers | Doses per pen / pack | Contents |
|---|---|---|---|
| 1.5 mg tablet | 1.5 mg per tablet | Bottle of 30 tablets | White to light yellow, round, debossed "1.5" and "novo" |
| 4 mg tablet | 4 mg per tablet | Bottle of 30 tablets | White to light yellow, round, debossed "4" and "novo" |
| 9 mg tablet | 9 mg per tablet | Bottle of 30 tablets | White to light yellow, round, debossed "9" and "novo" |
| 25 mg tablet | 25 mg per tablet | Bottle of 30 tablets | White to light yellow, oval, debossed "25" and "novo" |
The label reports these rates from placebo-controlled trials (label section 6.1). Percentages are the share of trial participants who reported each reaction.
| Adverse reaction | Placebo | Wegovy 25 mg tablet (N=204) |
|---|---|---|
| Stopped treatment due to adverse reactions | 5.9% | 6.9% |
| Stopped treatment due to gastrointestinal adverse reactions | 2% | 3.4% |
| Severe gastrointestinal adverse reactions | 0% | 2% |
| Dysesthesia (altered skin sensation) | 0% | 5% |
| Cholelithiasis (gallstones) | 1% | 2.5% |
When do they happen? The label presents the 30-day escalation steps as a way to reduce the risk of gastrointestinal adverse reactions (2.3); it does not give a tablet-specific statement on when these reactions occur.
The label also carries warnings that are not in this table (for example, a boxed warning or pancreatitis and gallbladder warnings where applicable). Read the full label linked under Sources, and report side effects to your prescriber.
Per the label, a missed Wegovy tablet dose is skipped, and the next dose is taken the following day. The label limits use to one tablet per day (2.1). (label section 2.4) The full walk-through is on the Wegovy pill missed-dose page.
The label describes one tablet once daily on an empty stomach in the morning with water (up to 4 ounces), and no other liquids. The tablet is swallowed whole, not split, crushed, chewed or dissolved, followed by a wait of at least 30 minutes before eating, drinking or taking other oral medications. In studies, absorption was higher with a longer post-dose fast (12.3). (label section 2.1; 12.3)
A simple log makes each titration step easier to talk through with your prescriber. These are the things worth writing down, and how Dose Track handles them:
Your log stays on your phone. See GLP-1 tracking in Dose Track for the full feature list.
Reviewed as of . Section numbers above refer to the FDA prescribing information.
All GLP-1 brand guides · GLP-1 tracking · Supported medications